Home > News > Recent cases

Phil & Ted’s Most Excellent Buggy Company -and- TFK Trends For Kids GmbH8 May 2013Andrew Lykiardopoulos recently acted for Phil & Ted’s Most Excellent Buggy Company in a patent dispute in the Patents County Court against TFK Trends for Kids. The dispute concerned Phil & Ted’s “Promenade” buggy. TFK said that the Promenade infringed their patent (which covered buggies which can convert between a seat and a carrycot). His […]
Public Relations Consultants Association Ltd v The Newspaper Licensing Agency Ltd [2013] UKSC 1823 April 2013Andrew Lykiardopoulos recently appeared in the Supreme Court, led by Henry Carr QC in The Newspaper Licensing Agency Limited v. Meltwater & the PRCA [2013] UKSC 18. The case concerned whether viewing or reading a web page could amount to copyright infringement. In particular, the case concerned the scope of the temporary copying exception to […]
Merck Canada Inc v Sigma Pharmaceuticals PLC [2013] EWCA Civ 32618 April 2013Martin Howe QC and Isabel Jamal acted for the appellants in successfully persuading the Court of Appeal to make a preliminary reference on the interpretation of the so-called ‘Specific Mechanism’, which relates to the parallel importation of pharmaceuticals from Poland and other EU Accession States. The case was decided at first instance ([2012] EWPCC 18, […]
Lizzano Partitions (UK) Limited v Interiors Manufacturing Limited [2013] EWPCC 1211 April 2013Isabel Jamal recently appeared before His Honour Judge Birss QC in the Patents County Court in Lizzanno Partitions (UK) Limited v Interiors Manufacturing Limited [2013] EWPCC 12. She acted for the patentee who succeeded in defending an action for a declaration of non-infringement (in relation to which it brought a counterclaim for infringement) and a […]
Hospira UK Ltd v Novartis AG [2013] EWHC 516 (Pat)2 April 2013Michael Tappin QC recently acted for Generics (UK) Ltd (t/a Mylan), the second claimant in Hospira UK Ltd v Novartis AG [2013] EWHC 516 (Pat). This was a claim for revocation of two European patents relating to the intravenous administration of zoledronate for the treatment of osteoporosis, at intervals of at least six months. The […]